Which anesthesia is safer for Kids' brains? new trial to find out

NCT ID NCT07194109

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two anesthesia drugs—remimazolam and propofol—in 558 children aged 3 to 6 who are having their tonsils or adenoids removed. The main goal is to see which drug leads to better brain development 1 to 3 years after surgery. Children will be randomly assigned to receive one of the two drugs during their operation, and their thinking and memory skills will be tested later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

remimazolam

What this could lead to

If remimazolam proves better for children's brain development after surgery, it could become a preferred anesthesia option for young kids.

What could go wrong

This is a Phase 4 study comparing two known drugs, so no major breakthrough is expected. Results may show no difference or be limited to this specific surgery and age group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOTONSILLAR HYPERTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenoid hypertrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.